NIH Institute / Center · EY (NEI)
National Eye Institute
136 funded awards, $80.3M total, FY2023-FY2025.
NIH SBIR/STTR funding decisions are made by Institutes and Centers based on portfolio priorities, NOFO scope, and program officer judgment. Historical funding patterns do not guarantee future funding.
Technology areas funded by NEI
Limitations
- RePORTER includes funded projects only, not unfunded applications.
- Panel sidebar reflects panels that have appeared on funded records, not future assignment.
- FOA-route status reflects verification at the timestamp shown.
Pattern read
NEI funded 136 records / $80M, with a portfolio focused on ophthalmic research tools, small-molecule therapeutics for retinal and corneal disease, ophthalmic drug delivery, and retinal imaging. Median award is $591K. Concentration is 11%. STTR Phase II (R42 at 13) is notable relative to total volume. Vision research has had a steady SBIR presence; pitches framed around a specific ocular indication (AMD, diabetic retinopathy, glaucoma) have been most visible in the dataset.